NovoCure Limited (NVCR) revenue

Revenue · fiscal 2025
$655.35M

NovoCure Limited (NVCR) reported revenue of $655.35M in fiscal 2025 (the year ended December 31, 2025). That is 8.3% higher than the $605.22M of fiscal 2024. Figures as of 18 Nov 2026, 11:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$655.35M
Change on fiscal 2024
+8.3%
Growth, 5 years
+5.8% a year
Growth, 10 years
+34.8% a year
Highest on record
$655.35Mfiscal 2025
Lowest on record
$10.36Mfiscal 2013
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

NovoCure Limited revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 5.8% a year; over ten years the rate was 34.8% a year. Across the 13 fiscal years on record (2013–2025), the highest was $655.35M in fiscal 2025 and the lowest $10.36M in fiscal 2013.

History · 13 fiscal years

Revenue by fiscal year

NovoCure Limited revenue, year by year

NovoCure Limited (NVCR) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$655.35M 8.3% up
2024$605.22M 18.8% up
2023$509.34M 5.3% down
2022$537.84M 0.5% up
2021$535.03M 8.2% up
2020$494.37M 40.7% up
2019$351.32M 41.6% up
2018$248.07M 40.1% up
2017$177.03M 113.6% up
2016$82.89M 150.5% up
2015$33.09M 113.6% up
2014$15.49M 49.5% up
2013$10.36M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on NVCR

NovoCure Limited, figure by figure

NovoCure Limited (NVCR) overview: price, valuation and scorecard

NovoCure Limited revenue: questions and answers

What is NovoCure Limited's revenue?

NovoCure Limited (NVCR) reported revenue of $655.35M in fiscal 2025 (the year ended December 31, 2025). That is 8.3% higher than the $605.22M of fiscal 2024.

What is the growth rate of NovoCure Limited's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 5.8% a year; over ten years the rate was 34.8% a year.

What are the highest and lowest revenue figures on record for NovoCure Limited?

Across the 13 fiscal years on record (2013–2025), the highest was $655.35M in fiscal 2025 and the lowest $10.36M in fiscal 2013.

How is NovoCure Limited's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For NovoCure Limited it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “NovoCure Limited (NVCR) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/NVCR/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.